Logo-apb
Adv Pharm Bull. 2022;12(3): 490-508. doi: 10.34172/apb.2022.052
PMID: 35935056        PMCID: PMC9348538

Review Article

Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia

Rajalakshmi Rajendran 1 ORCID, Krishnakumar Neelakandha Menon 2 * , Sreeja Chandrasekharan Nair 1 * ORCID

Cited by CrossRef: 3


1- Sondhi P, Lingden D, Bhattarai J, Demchenko A, Stine K. Applications of Nanoporous Gold in Therapy, Drug Delivery, and Diagnostics. Metals. 2022;13(1):78 [Crossref]
2- Rajendran R, Kunnil A, Radhakrishnan A, Thomas S, Nair S. Current trends and future perspectives for enhanced drug delivery to central nervous system in treatment of stroke. Therapeutic Delivery. 2023;14(1):61 [Crossref]
3- Wani S, Singh S, Sharma N, Zahoor I, Grewal S, Gupta S. Transferosome-Based Intranasal Drug Delivery Systems for the Management of Schizophrenia: a Futuristic Approach. BioNanoSci. 2023; [Crossref]
4- Mathew A, Mohapatra S, Panonnummal R. Formulation and evaluation of magnesium sulphate nanoparticles for improved CNS penetrability. Naunyn-Schmiedeberg's Arch Pharmacol. 2023;396(3):567 [Crossref]